GC
STJ

Gratus Capital’s St Jude Medical STJ Stock Holding History

Gratus Capital’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-32,435
Closed -$2.6M – 187
2016
Q4 		$2.6M Hold
32,435
– – 0.39% 63
2016
Q3 		$2.59M Buy
32,435
+2,600
+9% +$210K 0.38% 64
2016
Q2 		$2.33M Buy
+29,835
New +$2.13M 0.34% 67

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Gratus Capital's STJ Position: Q1 2017 in Review

Gratus Capital sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 32,435 shares — an estimated $2.6M sold.

Gratus Capital first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $2.6M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Gratus Capital reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Gratus Capital sold 32,435 St Jude Medical shares in Q1 2017, an estimated $2.6M.
  • Gratus Capital first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
  • Gratus Capital's St Jude Medical position peaked at $2.6M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Gratus Capital's 13F filing for Q1 2017, filed 15 May 2017.